Pepetidomimetcs, Sars-CoV-2 cathepsin-L and main protein inhibition, Antiviral drugs, In silico design, In cell assays.
FLAP/sEH dual inhibitor, Antiinflammatory properties, Lipidomic profiling, In vivo activity